Literature DB >> 12699431

Regulation of CCR5 expression and MIP-1alpha production in CD4+ T cells from patients with rheumatoid arthritis.

C R Wang1, M F Liu.   

Abstract

Production of CCR5 expression and MIP-1alpha, a ligand of CCR5, by CD4+ T cells from patients with rheumatoid arthritis (RA) were studied. We analysed further the influence of IL-15 stimulation, CD40/CD40 ligand (CD40L) interaction and CCR5 promotor polymorphism. One hundred and fifty-five RA patients and another 155 age- and sex-matched healthy individuals were enrolled. Peripheral CD4+ and double negative (DN) T cells from patients had lower portions of CCR5, whereas synovial CD4+ and DN T cells showed a much higher CCR5 expression. IL-15 significantly up-regulated the expression of CCR5 on purified CD4+ T cells. CD40L expression on synovial CD4+ T cells was increased greatly in CCR5+ portions by IL-15. MIP-1alpha production by synovial CD4+ T cells was also enhanced by IL-15. Co-culture of CD40 expressing synovial fibroblasts with IL-15-activated synovial CD4+ T cells significantly increased MIP-1alpha production. Expression of CCR5 on patients' CD4+ T cells was not influenced by the promotor polymorphism of CCR5 gene. Taken together, these data suggest CCR5+CD4+ T cells infiltrate the inflamed synovium and IL-15 up-regulates CCR5 and CD40L expression further and enhance MIP-1alpha production in synovial CD4+ T cells. Production of MIP-1alpha by synovial fibroblasts is significantly increased by engagement of CD40 with CD40L. Synovial microenvironment plays a potential role in regulation of CCR5+CD4+ T cells in rheumatoid joints.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699431      PMCID: PMC1808713          DOI: 10.1046/j.1365-2249.2003.02126.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

Review 1.  The strategy of blocking the chemokine system to combat disease.

Authors:  A E Proudfoot; C A Power; T N Wells
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

Review 2.  NKT cells: facts, functions and fallacies.

Authors:  D I Godfrey; K J Hammond; L D Poulton; M J Smyth; A G Baxter
Journal:  Immunol Today       Date:  2000-11

Review 3.  The role of chemokines in linking innate and adaptive immunity.

Authors:  Andrew D Luster
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

4.  Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.

Authors:  E T Molenaar; A E Voskuyl; A Familian; G J van Mierlo; B A Dijkmans; C E Hack
Journal:  Arthritis Rheum       Date:  2001-05

5.  Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment.

Authors:  M F Liu; S C Chao; C R Wang; H Y Lei
Journal:  Autoimmunity       Date:  2001       Impact factor: 2.815

6.  Distribution of double-negative (CD4- CD8-, DN) T subsets in blood and synovial fluid from patients with rheumatoid arthritis.

Authors:  M F Liu; C Y Yang; S C Chao; J S Li; T H Weng; H Y Lei
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

7.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

8.  Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint.

Authors:  A E Koch; M V Volin; J M Woods; S L Kunkel; M A Connors; L A Harlow; D C Woodruff; M D Burdick; R M Strieter
Journal:  Arthritis Rheum       Date:  2001-01

Review 9.  Chemokines as regulators of T cell differentiation.

Authors:  S A Luther; J G Cyster
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

10.  Selective lymphocyte chemokine receptor expression in the rheumatoid joint.

Authors:  J H Ruth; J B Rottman; K J Katschke; S Qin; L Wu; G LaRosa; P Ponath; R M Pope; A E Koch
Journal:  Arthritis Rheum       Date:  2001-12
View more
  20 in total

1.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody.

Authors:  Pierre Portalès; Sylvie Fabre; Thierry Vincent; Caroline Desmetz; Brigitte Réant; Danièle Noël; Jacques Clot; Christian Jorgensen; Pierre Corbeau
Journal:  Immunology       Date:  2009-03-26       Impact factor: 7.397

3.  Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus.

Authors:  Shih-Yao Chen; Ming-Fei Liu; Pin-Yu Kuo; Chrong-Reen Wang
Journal:  Clin Rheumatol       Date:  2019-02-15       Impact factor: 2.980

4.  Changes in chemokine receptor expression of regulatory T cells after ex vivo culture.

Authors:  Rikhia Chakraborty; Cliona Rooney; Gianpietro Dotti; Barbara Savoldo
Journal:  J Immunother       Date:  2012-05       Impact factor: 4.456

Review 5.  Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis.

Authors:  Iain B McInnes; J Alastair Gracie
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

6.  Genetic polymorphisms in the CD40 ligand gene and Kawasaki disease.

Authors:  Fu-Yuan Huang; Tzu-Yang Chang; Ming-Ren Chen; Nan-Chang Chiu; Hsin Chi; Hung-Chang Lee; Shuan-Pei Lin; Chih-Kai Chen; Hui-Wen Chan; Wei-Fang Chen; Hsin-Fu Liu; Chen-Chung Chu; Marie Lin; Yann-Jinn Lee
Journal:  J Clin Immunol       Date:  2008-05-15       Impact factor: 8.317

7.  PECAM-1 gene polymorphisms and soluble PECAM-1 level in rheumatoid arthritis and systemic lupus erythematosus patients: any link with clinical atherosclerotic events?

Authors:  Omer Nuri Pamuk; Hilmi Tozkir; Mehmet Sevki Uyanik; Hakan Gurkan; Fatih Saritas; Julide Duymaz; Salim Donmez; Metin Yazar; Gulsum Emel Pamuk
Journal:  Clin Rheumatol       Date:  2014-09-10       Impact factor: 2.980

8.  Genetic polymorphism of 3' untranslated region of zeta-chain associated protein kinase 70 kDa in southern Taiwanese patients with rheumatoid arthritis.

Authors:  Shih-Yao Chen; Ming-Fei Liu; Chrong-Reen Wang
Journal:  Clin Rheumatol       Date:  2015-08-06       Impact factor: 2.980

9.  Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment.

Authors:  Qu Lin; Zhiming Lin; Jieruo Gu; Feng Huang; Tianwang Li; Qiujing Wei; Zetao Liao; Shuangyan Cao; Yingjuan Jiang; Jinxian Huang
Journal:  Rheumatol Int       Date:  2009-05-23       Impact factor: 2.631

Review 10.  Chemokines and chemokine receptors in arthritis.

Authors:  Zoltan Szekanecz; Aniko Vegvari; Zoltan Szabo; Alisa E Koch
Journal:  Front Biosci (Schol Ed)       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.